Omeros Corp. (OMER) Surged To A New High On FDA Breakthrough Designation

Omeros Corp. (OMER) announced Tuesday morning that the FDA has granted breakthrough therapy designation to OMS721 for the treatment of Immunoglobulin A nephropathy.

from RTT - Before the Bell http://ift.tt/2se7rY0
via IFTTT